Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
5.954
Zitationen
10
Autoren
2001
Jahr
Abstract
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the reduction in blood pressure it causes.
Ähnliche Arbeiten
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 · 25.486 Zit.
Prediction of Creatinine Clearance from Serum Creatinine
1976 · 15.332 Zit.
2013 ESH/ESC Guidelines for the management of arterial hypertension
2013 · 13.647 Zit.
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 · 13.232 Zit.
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
2017 · 12.662 Zit.